Objective: The aim of the study was to examine the adherence to a salt restriction diet and the effect of salt restriction on blood pressure in free living subjects with mildly elevated blood pressure. Design: Subjects with mildly elevated blood pressure participated in a controlled study on the effect of salt restriction on blood pressure. Subjects received oral and written instructions by a clinical nutritionist to reduce sodium chloride intake to ®ve grams per day. A low sodium bread (0.5%) was supplied free of charge for the subjects during the whole low-sodium period (between weeks 4 ± 24). Subjects and methods: Subjects were recruited from previous studies at the Kuopio Research Institute of Exercise Medicine and from local occupational health care services. Twenty-four men and 15 women aged 28 ± 65 y with the mean daytime ambulatory diastolic blood pressure between 90 ± 105 mmHg and of®ce diastolic blood pressure between 95 ± 115 mmHg were included in the study. Salt intake was monitored by 4-d food diaries and 24-h urinary sodium excretion. Results: Twenty percent of the subjects achieved a urinary sodium excretion level of less than 74 mmola24 h corresponding to a salt intake of ®ve grams per day. There was a signi®cant decline (7.1 AE 12.7a4.2 AE 7.5) in systolic and diastolic blood pressure levels during the salt restriction diet. Conclusions: Even moderate salt restriction seems to be effective in the treatment of mildly elevated blood pressure. However, the recommended salt intake level of less than ®ve grams per day is dif®cult to achieve even after intensive counselling and regular use of low salt bread.
Introduction
Salt restriction has been shown to be effective in the treatment of hypertension (Australian National Health and Medical Research Council, 1989; Cutler et al, 1997; Kumanyika et al, 1993; Richards et al, 1984) . In a metaanalysis, a reduction of 100 mmol in daily urinary sodium excretion decreased systolic blood pressure by an average of 3.7 mmHg and diastolic blood pressure by an average of 0.9 mmHg in hypertensive subjects (Midgley et al, 1996) . Moreover, salt restriction may enhance the antihypertensive effect of pharmacological treatments (Alderman, 1994) . Despite the therapeutic potential of sodium restriction in the treatment of hypertension, questions remain about how well hypertensive patients can comply with salt restriction and what is the effect of the level of salt restriction on blood pressure changes.
In a recent meta-analysis of randomized controlled trials (Midgley et al, 1996) , the average reduction in 24-h urinary sodium excretion was 95 mmol per day in hypertensive subjects. In community based intervention trials, the reduction in salt intake achieved seems to be somewhat less. Earlier results indicate that the achieved level of sodium intake seems to be meaningful for blood pressure level. In the study of Kumanyika et al (1993) greater declines in blood pressure were associated with lower levels of urinary sodium excretion.
A salt intake of less than ®ve grams per day is generally recommended for hypertensive patients (Wood et al, 1998) , and in the Nordic Nutrition Recommendations (1996) the recommended average intake of salt in adults is ®ve grams per day corresponding to a sodium chloride density of approximately 0.5 gaMJ in the diet. An average salt intake of less than six grams per day is recommended by the American Heart Association (Krauss et al, 1996) and by WHO (World Health Organization, 1999) to prevent hypertension.
In practice it may be dif®cult to reduce salt intake to the recommended level of ®ve grams per day since the average salt intake of people living in industrialized countries is ten gramsaday (Intersalt Cooperative Research Group, 1988) . However, it has been shown that it is possible to reduce salt intake with dietary counselling in hypertensive (Cohen et al, 1991; Nissinen et al, 1987) and in normotensive adults (Kumanyika et al, 1993; Lang et al, 1985; Pietinen et al, 1984) . However, only a few studies report the achievement of a salt intake of less than ®ve grams per day. Kumanyika et al (1993) reported that 39% of free living subjects attained the recommended salt intake of less than ®ve grams per day. It has been suggested that, in general, salt intake in the long-run cannot be reduced below ®ve g per day (Staessen et al, 1997) . However, Elmer et al (1991) concluded that in clinical trials the sodium excretion can be reduced to levels of 70 ± 100 mmol per day for up to four years which corresponds to a sodium chloride intake of 5 ± 7 g per day, assuming that the average urinary excretion of sodium corresponds to 86% of total sodium intake (Holbrook et al, 1984) .
The aim of this study was to investigate the adherence to salt restriction and its effects on blood pressure in free living subjects with mild hypertension.
Patients and study design
Subjects were recruited from previous studies at the Kuopio Research Institute of Exercise Medicine and from local occupational health care services. Ninety-nine subjects aged 28 ± 65 y with mildly to moderately elevated blood pressure were invited for closer evaluation. The main exclusion criteria were complicated hypertension, symptomatic coronary heart disease, heart failure, clinically signi®cant hepatic, renal, gastroenterological, neurologic, haematologic, cerebrovascular, endocrinological or metabolic disease except for well-controlled diabetes mellitus. Other exclusions were autoimmune disease, history of allergy and angioneurotic oedema, drug or alcohol abuse and clinically signi®cant cardiac arrhythmias and conduction disturbances. Thirty-nine subjects (24 men, 15 women) aged 28 ± 65 y with a mean daytime ambulatory diastolic blood pressure between 90 ± 105 mmHg and diastolic blood pressure 95 ± 115 mmHg recorded in a doctor's of®ce were included in the study in free living conditions in years 1993 and 1994. The subjects participated in a placebo controlled study on the effects of salt restriction alone or in combination with cilazapril for the treatment of mildly elevated blood pressure (Uusitupa et al, 1996) . This article presents sodium intake and sodium excretion results from the salt restriction period with placebo or cilazapril treatment. However, the blood pressure data for cilazapril treatment is not included in this paper.
During the 4-week run-in period, the subjects followed their normal-sodium diet and took one placebo tablet daily given as control for the cilazapril arm of the study. Due to the normalisation of blood pressure during the run-in period, 14 subjects were excluded. At week 4 the 45 subjects who still ful®lled the inclusion criteria for blood pressure were instructed to follow a low-sodium diet for the next 8 weeks and they were given placebo tablets. At 12 weeks the subjects were randomised into two groups: low sodium placebo group and low-sodium cilazapril group. Subjects were asked to maintain their physical activity and to keep body weight unchanged during the study. There were six drop-outs during the study phase: four subjects withdrew because they were unwilling to continue the study, one subject because of side effects of cilazapril and one subject because of elevated blood pressure. The characteristics of the 39 subjects who ®nished the study are shown in Table 1 . Subjects gave their written informed consent for the study, and the study protocol was approved by the Ethics Committee of the University of Kuopio.
The visits to the research unit were arranged at baseline and at 4, 12, 18 and 24 weeks. The following examinations were carried out at baseline: medical history, physical examination, blood pressure in the of®ce, ambulatory blood pressure, heart rate, weight, ECG and laboratory examinations (Uusitupa et al, 1996) . Of®ce blood pressure, ambulatory blood pressure, heart rate and weight were measured, and laboratory examinations performed and adverse events were recorded at 4, 12, 18 and 24 weeks. The 24-h urinary sodium and potassium excretion were determined at the baseline and at 4, 12, 18 and 24 weeks.
Methods

Diet
At the beginning of the salt restriction period at week 4 the patients received oral and written instructions on how to choose and prepare food to reduce their daily sodium chloride intake to ®ve grams per day. Dietary instructions were provided by a clinical nutritionist. The patients were advised to reduce their sodium chloride intake, but otherwise the diet should remain similar to the run-in period diet. The diets were composed of normal Finnish food items. A low sodium bread (0.5%) was supplied free of charge to the subjects during the whole low-sodium period (between weeks 4 ± 24). Subjects were advised to used 50% less salt than in normal Finnish cooking and baking and tō avour foods using lemon, pepper, herbs, spices, onion and garlic. The patients were also asked to eat low-sodium alternatives of meat products, ®sh products, cereals and dairy products, and they also participated once or twice in group meetings during which they prepared dishes without salt. Those subjects eating lunch outside of the home were asked to order a salt-free lunch.
Data on the food consumption were collected three times, before weeks 4, 12 and 24 visits to the research unit, using 4-d food records (three weekdays and one weekend day). The amount of foods consumed was assessed by using a portion size booklet and household measures. Subject also wrote the recipes of home-made dishes and pastry in the food record. At every visit the subjects met the nutritionist who advised them on the practical management of the diets and checked the food records for complementing data that were lacking. The analysis of nutrients was made using the Nutrica 1 software package (Social Insurance Institution, Helsinki, Finland 1993).
Laboratory measurements
Body weight was measured in light clothes with the same digital scale (Seca, mode 708, Vogel & Halke GmbH & Co, Hamburg, Germany). The blood pressure was measured in the sitting position by the same trained nurse with a random zero sphygmomanometer (Hawksley & Sons Limited, England) between 0800 ± 1200 h after 10 ± 15 min rest. Disappearance of Korotkoff's sounds (phase V) was used in the determination of the diastolic blood pressure. Three measurements were done and the mean of the last two was used in the analysis. The 24-h ambulatory blood pressure was measured with a Novacor SA, (Rueil-Malmaison, France) at 20 min intervals between 0600 ± 2200 h and once an hour during the night time. The mean value over the registered time-period was used.
The 24-h urine collection was performed under free living conditions. The urine was collected in plastic containers from 0700 h to the next morning at 0700 h. The completeness of the collection was ascertained from the subjects when they returned the containers and urinary volume was measured. Completeness of urine excretion was con®rmed on the basis of the 24-h creatinine excretion. Sodium levels in urine were determined using ion selective electrodes (Kone Microlyte Ion Selective Analyzer, Kone Corporation, Espoo, Finland). Creatinine concentrations in serum and urine were analysed by the Jaffe method (Boehninger Mannheim GmbH, Germany).
Statistical analyses
Data were analysed using SPSS for Windows statistical package (SPSS Inc., Chicago, IL, USA). The normality of the distribution of variables was checked with the Kolmogorov-Smirnov (Lilliefors) test or with Shapiro-Wilks test before further analyses. Changes in dietary intake and daily urinary sodium excretion during the salt restriction period were analysed with Friedman two-way analysis of variance. Linear correlations between variables were analysed with Spearman correlation coef®cient. The difference in relative portions of subjects in the different 24-h urinary sodium excretion groups was tested between gender groups using w 2 test. Differences in blood pressure, body weight and body mass index between the study weeks 4 and 12 were analysed by Wilcoxon Matched-pairs Signed-ranks Test. A P-value of 0.05 was considered statistically signi®cant.
Results
Thirty-nine subjects (24 men, 15 women) aged 28 ± 65 y participated in a placebo controlled study on the effects of salt restriction alone or in combination with cilazapril for the treatment of mildly elevated blood pressure (Table 1) . The systolicadiastolic blood pressure decreased in men signi®cantly by 7.5 AE 12.3a3.8 AE 7.5 (mean AE s.d.) mmHg (P 0.0129, P 0.0285), respectively, during the eight weeks (weeks 4 ± 12) on salt restriction with placebo treatment. In women, the systolic blood pressure decreased by 6.5 AE 13.7 mmHg (P 0.691) and the reduction in diastolic blood pressure was 4.8 AE 7.8 mmHg (P 0.0382).
The body weight changed in both genders, but not statistically signi®cant between weeks 4 and 12 on salt restriction. The body weight changed from 88.3 AE 12.0 kg at week 4 to 87.4 AE 11.0 kg at week 12 in men, and in women from 78.1 AE 9.1 kg to 77.2 AE 8.6 kg. The change in BMI during salt restriction diet was small but not statistically signi®cant in either men (29.0 AE 3.2 kgam 2 at week 4, 28.8 AE 2.9 kgam 2 at week 12) or women (30.3 AE 3.5 kgam 2 and 30.0 AE 3.5 kgam 2 at week 12). Dietary sodium intake based on the food records decreased signi®cantly (P`0.001) in both sexes during the salt restriction period lasting 20 weeks (study weeks 4 ± 24) ( Table 2 ). In men the decrease was 1878 AE 1338 mg per day and in women 1374 AE 786 mg per day. The correlation between the salt intake measured by food record and by 24-h urinary sodium excretion was weak in all study weeks, r 0.279, P 0.086 at week 4; r 0.397, P 0.012 at week 12 and r 0.483, P 0.002 at week 24 (Figure 1 ).
The energy intake at baseline (at week 4) was 9119 AE 2275 kJ in men and 6353 AE 1577 kJ in women. The energy intake of women remained the same during the salt restriction period, but it decreased signi®cantly in men (1060 AE 2036 kJ) between weeks 4 and 12 (P`0.001). The energy intake from fat was 34 AE 7% in men and 35 AE 8% in women at baseline with no signi®cant reductions during the study period ( Table 2) .
The daily urinary sodium excretion decreased signi®-cantly (P`0.001) in combined group of men and women during the salt restriction period (Figure 2 ). In men, 24-h sodium excretion decreased by 88.1 AE 71.5 mmol and in women the decrease was 82.4 AE 51.7 mmol from week 4 to week 24. The mean level of 24-h sodium excretion was 132.8 AE 65.0 mmol in men at week 24 and Signi®cance in differences in women among 4, 12 and 24 weeks analysed with nonparametric Friedman two-way ANOVA test.
Salt restriction and elevated blood pressure MH Korhonen et al 79.7 AE 25.5 mmol in women. These excretions correspond to sodium chloride intakes of 9.0 g per day in men and 5.4 g per day in women. A total of 20% of the subjects at the study weeks 12 and 24 achieved the urinary sodium excretion level of less than 74 mmola24 h corresponding to a salt intake of ®ve grams per day (Table 3) . More women (47%) than men (8%) attained the targeted sodium excretion of less than 74 mmola24 h at week (P 0.0039).
Discussion
The main purpose of this study was to investigate the adherence to a salt restricted diet and its effects on mildly elevated blood pressure in a study investigating the effects of salt restriction alone or in combination with cilazapril for the treatment of mildly elevated blood pressure. The blood pressure decreased signi®cantly during the salt restriction diet, despite the fact that during the salt restriction which lasted for 20 weeks, only 20% of motivated home living subjects had been able to reduce their salt intake to less than ®ve grams per day.
In our study the compliance rate was not as high as that reported by Kumanyika et al (1993) . In their study, 39% of free living subjects achieved the urinary sodium excretion level of less than 74 mmola24 h corresponding to a salt intake of ®ve grams or less per day. Some clinical trials have demonstrated the feasibility of reducing sodium intake to levels of 70 ± 100 mmoladay for up to 4 y (Elmer et al, 1991) . In our study 47% of women attained the 24-h sodium excretion of 74 mmol. The main reason for why women could achieve more often the targeted sodium intake is their lower energy intake. Due to the differences Salt restriction and elevated blood pressure MH Korhonen et al in energy and nutrient intakes between men and women, the nutrient intakes and 24-h sodium excretion data have been presented separately for both genders in this study.
The heterogenous blood pressure responses to the changes in dietary salt intake in earlier studies could be due to the low compliance rate, also shown in this study, or due to the differences in salt sensitivity. There is a phenomenon called salt sensitivity when some individuals respond to salt restriction with decrease in blood pressure and others do not. Falkner & Michel (1997) have suggested that salt sensitivity appears to be linked to other risks for hypertension, including age, family history of hypertension, and obesity. In the future it is essential to take salt sensitivity into account when the effects of salt restriction on blood pressure are being evaluated.
The net mean decrease of 85.9 mmola24 h in urinary sodium excretion of the present study is consistent with earlier studies (Australian National Health and Medical Research Council, 1989; Kumanyika et al, 1993; MacGregor et al, 1982; Midgley et al, 1996) . Not all studies have been able to show that dietary instructions to reduce salt intake in hypertensive subjects actually lead to salt reduction. In the study by Alli et al (1992) dietary advice was given by general practitioners not by nutritionists. Furthermore, single short counselling sessions with advice on salt restriction have not been successful in producing dietary changes (Elmer et al, 1991) , and thus more comprehensive nutrition and behavior oriented programs that provide follow-up contacts are needed to achieve signi®cant sodium reduction in clinical settings. In the present study, the acceptance of salt restriction were strengthened by the supply of low salt bread and regular follow-up contacts.
In this study, the subjects were advised to change only the salt intake in their diet. Nonetheless, the energy intake of men also decreased 1060 kJad between weeks 4 and 24, which agrees with an earlier ®nding (Kumanyika et al, 1993) . Generally, the energy intake has remained the same in studies where the goal has been to maintain weight Wassertheil-Smoller et al, 1985; Witschi et al, 1985) . In studies where subjects were asked to reduce sodium intake and not asked to maintain their calorie intake, the energy and nutrient intakes have often decreased (Gillum et al, 1983; McCarron et al, 1997; Nowson & Morgan, 1985; Wylie-Rosett et al, 1993) .
Urinary sodium excretion has been shown to be a good measure of short-term sodium intake (Willett, 1990) . In this study change in sodium intake was similar when measured by urinary sodium excretion or by food records and the urinary sodium excretion and sodium intake by food records correlated relatively well. Caggiula et al (1985) also observed a high correlation (r 0.61) between the sodium intake estimated from food records and a single 24-h urinary sodium excretion measurement.
Conclusion
In summary, these ®ndings imply that it is possible to reduce salt intake in mildly hypertensive subjects, though a salt intake level of less than ®ve grams per day is dif®cult to achieve even after intensive counselling and the use of low salt bread. Furthermore, these results indicate that salt restriction seems to be effective in controlling blood pressure levels. Salt restriction should be recommended for the treatment of mildly elevated hypertension. Due to the dif®culty in maintaining salt restriction, long term counselling and follow-up contacts, as well as the reduction in the salt content of processed foods are needed.
